Radiofrequency Ablation for Polymorphic Ventricular Tachycardia With Heart Failure (RFCA for PMVT-HF)
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 118 participants.
Also called NCT07130175
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 118 participants
- Sponsor
- Qian Feng
- Registry
-
NCT07130175
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT07130175. Randomized; no masking; primary purpose treatment. Start 2022-12-31 (actual); primary completion 2024-12-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Radiofrequency Ablation for Polymorphic Ventricular Tachycardia With Heart Failure (RFCA for PMVT-HF)
- Condition
- Polymorphic Ventricular Tachycardia
- Condition
- Heart Failure
- Intervention (Device)
- Radiofrequency Catheter Ablation
- Intervention (Drug)
- Guideline-Directed Medical Therapy (GDMT)
- Lead sponsor
- Qian Feng
- Collaborator
- The First Hospital of Zhangjiakou City
Record details
- Record id
cardio:ct-nct07130175- Content hash
0c2294846ee7ed71efbb290e9360fe8f1bc5c2fb010ae00ed20dd4c82f32b823